280 related articles for article (PubMed ID: 15047237)
1. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.
Brooks SE; Zhan M; Cote T; Baquet CR
Gynecol Oncol; 2004 Apr; 93(1):204-8. PubMed ID: 15047237
[TBL] [Abstract][Full Text] [Related]
2. Uterine Sarcoma: Analysis of 13,089 Cases Based on Surveillance, Epidemiology, and End Results Database.
Hosh M; Antar S; Nazzal A; Warda M; Gibreel A; Refky B
Int J Gynecol Cancer; 2016 Jul; 26(6):1098-104. PubMed ID: 27177280
[TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis of 80 cases with uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma in China, 1988-2007.
Gao Y; Meng H; Zhang Y; Jiao T; Hui N
Int J Clin Exp Pathol; 2014; 7(4):1616-24. PubMed ID: 24817958
[TBL] [Abstract][Full Text] [Related]
4. Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus.
Sherman ME; Devesa SS
Cancer; 2003 Jul; 98(1):176-86. PubMed ID: 12833470
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic differences account for racial disparity in uterine cancer survival.
Smotkin D; Nevadunsky NS; Harris K; Einstein MH; Yu Y; Goldberg GL
Gynecol Oncol; 2012 Dec; 127(3):616-9. PubMed ID: 22940487
[TBL] [Abstract][Full Text] [Related]
6. Uterine Sarcomas in Patients Undergoing Surgery for Presumed Leiomyomas: 10 Years' Experience.
Paul PG; Rengaraj V; Das T; Garg R; Thomas M; Khurd AS
J Minim Invasive Gynecol; 2016; 23(3):384-9. PubMed ID: 26677821
[TBL] [Abstract][Full Text] [Related]
7. Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality.
Nordal RR; Thoresen SO
Eur J Cancer; 1997 May; 33(6):907-11. PubMed ID: 9291814
[TBL] [Abstract][Full Text] [Related]
8. [Uterine sarcoma. Apropos of 25 cases].
Bennani O; Himmi A; Laghzaoui M; Aderdour M
Rev Fr Gynecol Obstet; 1995 Jan; 90(1):12-6. PubMed ID: 7899765
[TBL] [Abstract][Full Text] [Related]
9. Uterine sarcomas in South African black women: a clinicopathologic study with ethnic considerations.
Amant F; Dreyer L; Makin J; Vergote I; Lindeque BG
Eur J Gynaecol Oncol; 2001; 22(3):194-200. PubMed ID: 11501770
[TBL] [Abstract][Full Text] [Related]
10. Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma.
Nasioudis D; Chapman-Davis E; Frey M; Holcomb K
J Gynecol Oncol; 2017 Jul; 28(4):e46. PubMed ID: 28541635
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of sarcomas of the uterus.
Harlow BL; Weiss NS; Lofton S
J Natl Cancer Inst; 1986 Mar; 76(3):399-402. PubMed ID: 3456457
[TBL] [Abstract][Full Text] [Related]
12. High incidence of gynecologic sarcomas in Israel-A comparison to European and American reports: Gynecologic Sarcoma in Israel.
Brudner Y; Salman L; Haran G; Blecher A; Hallak M; Bruchim I
Maturitas; 2021 Dec; 154():1-6. PubMed ID: 34736574
[TBL] [Abstract][Full Text] [Related]
13. Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma.
Akahira J; Tokunaga H; Toyoshima M; Takano T; Nagase S; Yoshinaga K; Tase T; Wada Y; Ito K; Niikura H; Yamada H; Sato A; Sasano H; Yaegashi N
Oncology; 2006; 71(5-6):333-40. PubMed ID: 17690557
[TBL] [Abstract][Full Text] [Related]
14. Outcome of adjuvant radiotherapy after total hysterectomy in patients with uterine leiomyosarcoma or carcinosarcoma: a SEER-based study.
Li Y; Ren H; Wang J
BMC Cancer; 2019 Jul; 19(1):697. PubMed ID: 31307426
[TBL] [Abstract][Full Text] [Related]
15. The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases.
Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Cosio S; Tisi G; Lissoni A; Ferrero AM; Cristofani R
Eur J Gynaecol Oncol; 2002; 23(4):295-9. PubMed ID: 12214727
[TBL] [Abstract][Full Text] [Related]
16. Current concepts in the imaging of uterine sarcoma.
Tirumani SH; Ojili V; Shanbhogue AK; Fasih N; Ryan JG; Reinhold C
Abdom Imaging; 2013 Apr; 38(2):397-411. PubMed ID: 22699695
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors, oncological treatment and outcomes of uterine sarcoma: 10 years' clinical experience from a tertiary care center in Pakistan.
Khan SR; Soomar SM; Asghari T; Ahmed A; Moosajee MS
BMC Cancer; 2023 Jun; 23(1):510. PubMed ID: 37277708
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers.
Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
Tumour Biol; 2011 Jun; 32(3):451-9. PubMed ID: 21161468
[TBL] [Abstract][Full Text] [Related]
19. Trends of uterine carcinosarcoma in the United States.
Matsuo K; Ross MS; Machida H; Blake EA; Roman LD
J Gynecol Oncol; 2018 Mar; 29(2):e22. PubMed ID: 29400015
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant radiation therapy in uterine carcinosarcoma: A population-based analysis of patient demographic and clinical characteristics, patterns of care and outcomes.
Manzerova J; Sison CP; Gupta D; Holcomb K; Caputo TA; Parashar B; Nori D; Wernicke AG
Gynecol Oncol; 2016 May; 141(2):225-230. PubMed ID: 26896827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]